Home page Home page

Ranexa (previously Latixa)
ranolazine

Package leaflet: Information for the patient


Ranexa 375 mg prolonged-release tablets Ranexa 500 mg prolonged-release tablets Ranexa 750 mg prolonged-release tablets

ranolazine


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.


are taking Ranexa.


Tell your doctor or pharmacist if you are using or have recently used or might use any other medicines.


Ranexa with food and drink

Ranexa can be taken with or without food. While being treated with Ranexa, you should not drink grapefruit juice.


Pregnancy

You should not take Ranexa if you are pregnant unless your doctor has advised you to do so.


Breast-feeding

You should not take Ranexa if you are breast-feeding. Ask your doctor for advice if you are breast- feeding.


If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.


Driving and using machines

No studies on the effects of Ranexa on the ability to drive and use machines have been performed. Ask your doctor for advice about driving or using machines.


Ranexa may cause side effects such as dizziness (common), blurred vision (uncommon), confusional state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems

(rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not drive or operate machinery until they have resolved completely.


Ranexa 750 mg prolonged-release tablets contain the azo colouring agent E102. This colouring agent- may cause allergic reactions.


Ranexa 750 mg prolonged-release tablets contain lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


This medicine contains less than 1 mmol sodium (23 mg) per prolonged-release tablet, that is to say essentially ‘sodium-free’.


  1. How to take RANEXA


    Always take this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist if you are not sure.


    Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in half, as this might affect the way the medicine is released from the tablets into your body.


    The starting dose for adults is one 375 mg tablet twice a day. After 2−4 weeks, your doctor may

    increase the dose to get the right effect. The maximum dose of Ranexa is 750 mg twice a day.


    It is important that you tell your doctor if you get side effects such as dizziness or feeling or being sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranexa.


    Use in children and adolescents

    Children and adolescents under 18 years old should not take Ranexa.


    If you take more Ranexa than you should

    If you accidentally take too many Ranexa tablets or take a higher dose than recommended by your doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the nearest accident and emergency department. Take along any tablets that are left, including the container and the carton, so that the hospital staff can easily tell what you have taken.


    If you forget to take Ranexa

    If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) to take your next dose. Do not take a double dose to make up for a forgotten dose.


  2. Possible side effects


    Like all medicines, this medicine can cause side effects, although not everybody gets them.


    You should stop taking Ranexa and see your doctor immediately if you experience the following symptoms of angioedema, which is a rare condition but can be severe:

    • swollen face, tongue, or throat

    • difficulty swallowing

    • hives or difficulty breathing


    Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting. Your doctor may lower your dose or stop treatment with Ranexa.


    Other side effects you may experience include the following:

    Common side effects (occur in 1 to 10 users in 100) are: Constipation

    Dizziness

    Headache

    Feeling sick, vomiting Feeling weak


    Uncommon side effects (occur in 1 to 10 users in 1,000) are: Altered sensation

    Anxiety, difficulty sleeping, confusional state, hallucination

    Blurred vision, visual disturbance

    Changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, faint or fainting, dizziness upon standing

    Dark urine, blood in urine, difficulty urinating Dehydration

    Difficulty breathing, cough, nose bleed Double vision

    Excessive sweating, itching

    Feeling swollen or bloated

    Hot flushes, low blood pressure

    Increases in a substance called creatinine or increases in urea in your blood, increase in blood platelets or white blood cells, changes in ECG heart tracing

    Joint swelling, pain in extremity

    Loss of appetite and/or weight loss Muscle cramp, muscle weakness

    Ringing in the ears and/or feeling a spinning sensation Stomach pain or discomfort, indigestion, dry mouth, or wind


    Rare side effects (occur in 1 to 10 users in 10,000) are: A lack of ability to urinate

    Abnormal laboratory values for liver Acute kidney failure

    Change in sense of smell, numbness in mouth or lips, impaired hearing Cold sweat, rash

    Coordination problems

    Decrease in blood pressure upon standing Decreased or loss of consciousness Disorientation

    Feeling of coldness in hands and legs Hives, allergic skin reaction

    Impotence

    Inability to walk due to imbalance Inflammation of pancreas or intestine

    Loss of memory

    Throat tightness

    Low level of sodium in the blood (hyponatremia) which can cause tiredness and confusion, muscle twitching, cramps, and coma.


    Not known side effects (frequency cannot be estimated from the available data) are: Myoclonus


    Reporting of side effects


    If you get any any side effects talk to your doctor or pharmacist. This include any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system

    listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


  3. How to store RANEXA


    Keep this medicine out of the sight and reach of children.


    Do not use this medicine after the expiry date which is stated on each blister strip of tablets and on the outside of the carton and bottle after EXP.


    This medicinal product does not require any special storage conditions.


    Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


  4. Contents of the pack and other information What Ranexa contains

The active substance in Ranexa is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg ranolazine.


The other ingredients are: hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, sodium hydroxide, titanium dioxide and carnauba wax.


Depending on the tablet strength, the tablet coatings also contain:

375 mg tablet: macrogol, polysorbate 80, Blue #2/Indigo Carmine Aluminium Lake (E132)

500 mg tablet: macrogol, talc, polyvinyl alcohol-part hydrolyzed, iron oxide yellow (E172), iron oxide red (E172)

750 mg tablet: glycerol triacetate, lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminium Lake (E133) and Yellow #5/Tartrazine Aluminium Lake (E102)


What Ranexa looks like and contents of the pack

Ranexa prolonged-release tablets are oval shaped tablets.

The 375 mg tablets are pale blue and are engraved with 375 on one side. The 500 mg tablets are light orange and are engraved with 500 on one side. The 750 mg tablets are pale green and are engraved with 750 on one side.


Ranexa is supplied in cartons containing 30, 60, or 100 tablets in blister strips or 60 tablets in plastic bottles. Not all pack-sizes may be marketed.


Marketing Authorisation Holder

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg


Manufacturer


Menarini - Von Heyden GmbH Leipziger Straβe 7-13

01097 Dresden Germany


or


Berlin-Chemie AG Glienicker Weg 125

12489 Berlin Germany


For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder.


België/Belgique/Belgien Menarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545

Lietuva

UAB “BERLIN-CHEMIE MENARINI BALTIC”

Tel: +370 52 691 947


България

“Берлин-Хеми/А. Менарини България” ЕООД

тел.: +359 2 454 0950

Luxembourg/Luxemburg Menarini Benelux NV/SA Tél/Tel: + 32 (0)2 721 4545


Česká republika

Berlin-Chemie/A.Menarini Ceska republika s.r.o.

Tel: +420 267 199 333

Magyarország

Berlin-Chemie/A. Menarini Kft.

Tel.: +36 23501301


Danmark

Menarini International Operations Luxembourg S.A.

Tel: +352 264976

Malta

Menarini International Operations Luxembourg S.A.

Tel: +352 264976


Deutschland

Berlin-Chemie AG Tel: +49 (0) 30 67070

Nederland

Menarini Benelux NV/SA Tel: +32 (0)2 721 4545


Eesti

OÜ Berlin-Chemie Menarini Eesti Tel: +372 667 5001

Norge

Menarini International Operations Luxembourg S.A.

Tlf: +352 264976


Ελλάδα MENARINI HELLAS AE Τηλ: +30 210 8316111-13

Österreich

  1. Menarini Pharma GmbH. Tel: +43 1 879 95 85-0


España

Laboratorios Menarini S.A. Tel: +34-93 462 88 00

Polska

Berlin-Chemie/Menarini Polska Sp. z o.o.

Tel.: +48 22 566 21 00


France

MENARINI France Tél: +33 (0)1 45 60 77 20

Portugal

A. Menarini Portugal – Farmacêutica, S.A. Tel: +351 210 935 500


Hrvatska

Berlin-Chemie Menarini Hrvatska d.o.o.

Tel: + 385 1 4821 361

România

Berlin-Chemie A. Menarini S.R.L. Tel: +40 211 232 34 32

Ireland

A. Menarini Pharmaceuticals Ltd Tel: +353 1 284 6744

Slovenija

Berlin-Chemie / A. Menarini Distribution Ljubljana d.o.o.

Tel: +386 01 300 2160


Ísland

Menarini International Operations Luxembourg S.A.

Sími: +352 264976

Slovenská republika

Berlin-Chemie / A. Menarini Distribution Slovakia s.r.o

Tel: +421 2 544 30 730


Italia

  1. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Tel: +39-055 56801

    Suomi/Finland

    Berlin-Chemie/A.Menarini Suomi OY Puh/Tel: +358 403 000 760


    Κύπρος MENARINI HELLAS AE Τηλ: +30 210 8316111-13

    Sverige

    Menarini International Operations Luxembourg S.A.

    Tel: +352 264976


    Latvija

    SIA Berlin-Chemie/Menarini Baltic Tel: +371 67103210

    United Kingdom (Northern Ireland)

    1. Menarini Farmaceutica Internazionale S.R.L. Tel: +44 (0)1628 856400


This leaflet was last revised in


.eu.